论文部分内容阅读
水痘减毒活疫苗系采用水痘-带状疱疹病毒(varicella-herpes zoster virus,VZV)接种人二倍体细胞,经培养,收获病毒,加入适宜稳定剂冻干制成,用于预防由VZV感染引起的急性传染病,目前属于国家免疫规划管理中的二类疫苗。该产品于2000年在我国批准上市,2015年首次纳入《中国药典》(Chinese Pharmacopoeia,ChP)三部收载。本文
The live attenuated varicella vaccine was inoculated into human diploid cells with varicella-herpes zoster virus (VZV), and the virus was harvested and freeze-dried with appropriate stabilizers to prevent infection by VZV The acute infectious diseases that are caused are currently two types of vaccines in the management of national immunization programs. The product was approved for listing in China in 2000 and for the first time in 2015 was incorporated into the Chinese Pharmacopoeia (ChP). This article